Related Experiment Videos

[Mediators involved in the nephrotoxicity of cyclosporin A]

N Simon1, J Barré, P Jolliet

  • 1Service Hospitalo-Universitaire de Pharmacologie, Université de Paris XII, Centre Hospitalier Intercommunal, Créteil, France.

Therapie
|July 1, 1997
PubMed

Insights

Cyclosporin A causes kidney damage through unclear mechanisms, potentially involving cellular calcium disruption. Understanding this is crucial for newer immunosuppressants with similar renal toxicity.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Context:

  • Cyclosporin A-induced nephrotoxicity is a recognized clinical issue.
  • Newer immunosuppressants like Cyclosporin G, FK 506, and rapamycin also exhibit renal toxicity.
  • The precise mechanisms underlying cyclosporin A nephrotoxicity remain incompletely understood.

Purpose:

  • To review the current understanding of cyclosporin A nephrotoxicity mechanisms.
  • To highlight the limitations of current hypotheses, such as renal vasoconstriction.
  • To propose alternative mechanisms, including cellular calcium homeostasis, for further investigation.

Summary:

  • Cyclosporin A administration causes renal vasoconstriction mediated by prostaglandins, sympathetic nerves, dopamine, nitric oxide (NO), and endothelin.
  • While vasoconstriction explains hemodynamic changes, it does not account for observed histological lesions.
  • Emerging hypotheses suggest that alterations in cellular calcium homeostasis may play a significant role in cyclosporin A-induced kidney damage.

Impact:

  • Clarifying cyclosporin A nephrotoxicity mechanisms is essential for managing patients on immunosuppressive therapy.
  • This knowledge can guide the development of safer immunosuppressant drugs.
  • Identifying novel therapeutic targets for preventing or treating drug-induced kidney injury.

Related Concept Videos